Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 348145, 7 pages
http://dx.doi.org/10.1155/2013/348145
Clinical Study

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients

Department of Cardiology, Second Affiliated Hospital, Zhejiang University, College of Medicine, No. 88 Jiefang Road, Hangzhou, Zhejiang 310009, China

Received 22 March 2013; Revised 1 May 2013; Accepted 12 May 2013

Academic Editor: Giuseppe Valacchi

Copyright © 2013 Yifei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Dorota Tulacz, Urszula Mackiewicz, Michal Maczewski, Agata Maciejak, Monika Gora, and Beata Burzynska, “Transcriptional profiling of left ventricle and peripheral blood mononuclear cells in a rat model of postinfarction heart failure,” Bmc Medical Genomics, vol. 6, 2013. View at Publisher · View at Google Scholar
  • Muhammad Hammadah, Yiying Fan, Yuping Wu, Stanley L. Hazen, and W. H. Wilson Tang, “Prognostic Value of Elevated Serum Ceruloplasmin Levels in Patients with Heart Failure,” Journal of Cardiac Failure, 2014. View at Publisher · View at Google Scholar
  • Kamilu M. Karaye, Isah A. Yahaya, Krister Lindmark, and Michael Y. Henein, “Serum Selenium and Ceruloplasmin in Nigerians with Peripartum Cardiomyopathy,” International Journal Of Molecular Sciences, vol. 16, no. 4, pp. 7644–7654, 2015. View at Publisher · View at Google Scholar
  • Filip Málek, Dagmar Vondráková, Oxana Komendová, Dana Říhová, Jana Vránová, Lenka Sedláčková, Táňa Andreasová, and Petr Neužil, “Correlation of Ceruloplasmin with Biomarkers of Cardiac Remodelling and Myofibrosis in Patients with Acute Decompensated Heart Failure Referred to a Tertiary Nurse Lead Heart Failure Clinic,” Open Journal of Nursing, vol. 05, no. 11, pp. 971–975, 2015. View at Publisher · View at Google Scholar
  • A. Savic-Radojevic, M. Pljesa-Ercegovac, M. Matic, D. Simic, S. Radovanovic, and T. Simic, “Novel Biomarkers of Heart Failure,” 2016. View at Publisher · View at Google Scholar
  • YiQiang Yuan, YuHao Liu, YuXiao Sun, ChuanYu Gao, XianQing Wang, and JunGe Jia, “Serum quantitative proteomic analysis of patients with keshan disease based on iTRAQ labeling technique: A first term study,” Journal of Trace Elements in Medicine and Biology, vol. 44, pp. 331–338, 2017. View at Publisher · View at Google Scholar
  • E. V. Loskutova, I. A. Vorontsova, H. M. Vahitov, I. H. Valeeva, O. I. Polyakova, L. F. Vahitova, O. N. Shibalova, I. T. Nuriahmetova, E. A. Sharafutdinova, and T. R. Safiullin, “The Condition Of The Lipoperoxidation System In Premature Newborns After Perinatal Hypoxia,” Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics), vol. 63, no. 5, pp. 135–138, 2018. View at Publisher · View at Google Scholar